Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Faculty
  • 12:30 AM – 1:00 AM ET
    Board of Chancellors
  • 12:30 AM – 1:00 AM ET
    Scientific Planning Committee (SPC)
  • 12:30 AM – 1:00 AM ET
    SEAL Faculty
  • A Comparative Analysis of Patient-Reported Fatigue Severity and Interference Among Patients with Breast Cancer Undergoing Chemotherapy and/or Radiotherapy
  • A Meta-analysis of the Efficacy of Hemi-body Irradiation
  • A prospective study on thoracic radiation therapy with deep inspiration breath hold guided by implanted electromagnetic transponders
  • A radiation oncologist's guide to contouring the Hypothalamus
  • Adaptive Radiation Therapy: What you need to know to create a successful program
  • Advancing Resident Education: Experiential Success in the Creation of a Comprehensive Clinical Didactic Series in Radiation Oncology
  • An Antidote to Decreasing Interest in Rad Onc: Earlier Engagement
  • AROPA: Transformational Leaders Who Have Implemented Change
  • Automation of Dosimetric Data Extraction for Gynecologic Intracavitary Brachytherapy Plans using the Eclipse Scripting Application Programming Interface
  • Barriers to Promotion: A Survey Study Investigating Obstacles to Women's Advancement in Radiation Oncology
  • Benefit of Scar Boost Following Postmastectomy Radiation in Female Breast Cancer: A Retrospective Analysis
  • Beyond the Cranium; A Case Report on the Risk Factors and Presentation of Metastatic Meningioma
  • Brain-Metastatic Prostate Adenocarcinoma: Avoiding Mistaken Identities
  • Breaking Barriers National Collaborative Highlights How Access to RT Can Be Improved Through QI Process
  • Breast Cancer: Patient awareness and Hormonal Status in Addis Ababa, Ethiopia
  • Building Multidisciplinary Collaboration Teams to Facilitate Care
  • Carbon footprint generated by a radiation oncology department at a tertiary care hospital in India
  • Case report of a patient with Neurofibromatosis type I and synchronous bilateral carcinoma breast
  • Case report of a patient with synchronous Non-Hodgkin’s lymphoma-Diffuse Large B-Cell type and Lymphocyte rich classic Hodgkin’s lymphoma
  • Case Report of Well-Tolerated Post-Mastectomy Chest Wall and Regional Nodal Irradiation in a Patient with Cowden’s Syndrome
  • Caught Between a ROCR and a Hard Place: Improving Proposed Radiation Oncology Alternative Payment Models
  • Clinical and Socioeconomic Factors Associated with Early Discontinuation of Radiation Therapy
  • Cognitive Processes Involved in Radiation Oncology Contouring: Protocol Analysis to Evaluate Framework and Develop Interventions to Improve Resident Education (ACRO Dr. Luther Brady Educational Grant Project)
  • Comparative effectiveness of adding metronidazole to chemoradiation in cervical cancer patients: a SEER-Medicare based study
  • Consensus on Payment Model Reform amongst Radiation Oncologists: The Radiation Oncology Payment Reform Survey, Preliminary Results
  • Cost-effectiveness analysis of the addition of metastasis directed therapy to intermittent hormone therapy for oligometastatic prostate cancer
  • Creating a Hybrid Schedule with Protected Remote Time at an Academic Institution
  • Curative Radiation as Monotherapy for Intrahepatic Cholangiocarcinoma: A Case Report
  • Daily accelerated partial breast irradiation (APBI) using external beam radiotherapy (EBRT). Is it safe?
  • Daily Reproducibility of Normal Structure Dosimetry in Single Insertion, Multi-Day Interstitial Gynecologic Brachytherapy
  • Definitive Ablative Radiation Therapy for Unresectable and Recurrent Intrahepatic Cholangiocarcinoma
  • Demonstrating FLASH effectiveness against CONV dose rates, on eradication of orthotopic breast cancer tumor model
  • Does Stereotype Threat Dissuade Women from Pursuing Technical Specialties Such as Radiation Oncology? Narratives from Thematic Content Analysis of Medical Student Interviews
  • Dosimetric and Cost Analysis of Treatment Methods for Whole Brain Radiation Therapy: 3D-CRT versus HA-IMRT
  • Dosimetric impact of PTV margin reduction in CT-guided compared with MRI-guided stereotactic body radiotherapy for localized prostate cancer
  • Early Implementation Outcomes of a Dedicated, Inpatient Radiation Oncology Consultation Service at a Public Academic Medical Center
  • Employee Relations Committee
  • Evidence-based risk stratified monitoring protocol for optic pathway late toxicity following head and neck & CNS radiotherapy
  • Examining the Relationship Between Adverse Childhood Experience Scores and Quality of Life Scores in Patients Undergoing Radiotherapy for Head and Neck Cancer
  • Extracranial Palliative Radiotherapy for Renal Cell Carcinoma
  • Extranodal Rosai-Dorfman Disease in the Pancreas: First Report of MRI-Guided Stereotactic Body Radiation Therapy
  • Forward Momentum: Progressive Change through Diversity, Equity and Inclusion Initiatives in Academic Healthcare
  • Fully remote management of patients treated with radiation as a component of patient-centered care: Safety, satisfaction, financial and environmental impact
  • FUNCTIONAL OUTCOMES FOLLOWING EXTERNAL BEAM RADIATION THERAPY FOR PATIENTS WITH PRIOR HOLMIUM LASER ENUCLEATION OF THE PROSTATE
  • Heidelberg Ion Therapy Center: Reflections and Lessons From My ACRO HIT Experience
  • Hypofractionated Pelvic Radiation Therapy Followed by Complex Brachytherapy Results in Adequate Disease Control and Limited Toxicity in Women with Uterine and Cervical Carcinoma
  • Impact of EGFR Mutational Status on SBRT Lung Oligometastatic Tumor Response
  • Implementation of a Holistic Review Pipeline of Radiation Oncology Residency Applicants: Initial Evaluation and Next Steps
  • Improving Educational Outcomes by Changing Up the Boring PowerPoint Lecture
  • Incident Learning Enhancement
  • Initial Patient Perspectives on a Novel Intervention for Radiation Dermatitis: A Single Institutional Experience
  • Institutional experience with multiple radiation fractionation regimens for the treatment of portal vein tumor associated thrombosis
  • Is there racial bias in the application of hypofractionated adjuvant radiotherapy for breast cancer that increases the burden of care in African American women within the UPMC system?
  • Leveraging Academic Community Collaboration to Improve Rural Outcomes in RT Planning and Use of NCCN Guidelines
  • Liver-sparing total body irradiation using helical tomotherapy
  • Local control, surgical outcomes, and post-operative complications in management of locally advanced rectal cancer with sequential neoadjuvant short-course radiation therapy and chemotherapy
  • Locally Advanced Pancreatic Cancer Case Report: ATM mutation in the setting of FOLFIRINOX and MRI guided SBRT leads to near complete pathological response
  • Long Term Outcomes Following Adjuvant Accelerated Partial Breast Radiotherapy for Early-Stage Breast Cancer: Are Current Guidelines for Appropriateness Appropriate?
  • Long Term Survival of a Patient with a Rare Mucinous Carcinoma Arising from Intraductal Papillary Mucinous Neoplasm Status Post R1 Distal Pancreatectomy/Splenectomy and Adjuvant Therapy: A Case Report
  • Mammary Paget’s Disease of the nipple as a sign of local recurrence two decades following properly treated breast cancer
  • Medicare reimbursement disparity between freestanding and hospital-based radiation oncology practices for commonly treated cancers
  • Minimization of Thoracic Vertebral Bone Marrow Irradiation during Intensity-Modulated Radiation Therapy of Esophageal and Thoracic Malignancies
  • Modern Day Oncology for a Rare Pathology: Treatment Course of Rare Basaloid Non-Keratinizing Urethral Carcinoma
  • Nasopharyngeal carcinoma: Treatment Pattern and Survival in Addis Ababa, Ethiopia.
  • National trends in the treatment of Adult Diffuse Midline Gliomas: A Rare Clinical Scenario
  • Needs Assessment and Twinning Partnership to Improve Pediatric Radiotherapy Outcomes Globally
  • OU Health Stephenson Cancer Center Clinic Shuffle - Space Optimization Project
  • Outcomes of Transformed Diffuse Large B-cell Lymphoma
  • Palliative Quadshot Radiation Therapy with or without Concurrent Immune Checkpoint Inhibition for Head and Neck Cancer
  • Palliative Radiation Therapy in the Management of Colon Cancer Patients Unable to Undergo Surgical Resection
  • Para-Aortic Lymph Node Failure After Definitive Chemoradiation for Locally Advanced Cervical Cancer
  • Patient Experience: More Than Just A Number
  • Patient-Specific Segmentation-Based Treatment Planning vs NovoTAL for Tumor Treating Fields Therapy in Glioblastoma
  • Patterns of failure after Stereotactic Radiosurgery for Patients with 15 or more Brain Metastases
  • Perfuse Bleeding Following Interstitial Brachytherapy (ISBT) for Cervical Cancer Requiring Surgical Intervention
  • Perianal Paget's: Preserving Performance Status with Photons. A Case Series of Three Women with Extramammary Paget's Disease Treated with Primary Radiotherapy
  • Phase I Study of Niraparib with Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix (NIVIX)
  • Pilot study of Velocity-selective Arterial Spine label MRI (VSAL-MRI) derived relative cerebral blood flow to distinguish imaging changes after radiosurgery for brain metastasis from progressive tumor.
  • Pre-treatment Trends in Child-Pugh Score as an Indicator of Post-treatment Survival in Patients Receiving Liver Stereotactic body radiation therapy for Hepatocellular carcinoma
  • Prospective peer review as a component of a comprehensive quality program to reduce risk in the delivery of radiotherapy.
  • PULSE LOW DOSE RATE RADIATION THERAPY FOR RE-TREATMENT OF THE SAME DISEASE SITE WHICH NORMAL TISSUES TOLERENCES ARE AT OR NEARLY REACHED
  • Pulse Reduced Dose Rate Re-Irradiation for Recurrent Head and Neck Malignancies: A Single Institution Phase II Pilot Study
  • Quality Assurance Analysis of Protocol Deviations in a Radiation Oncology Department Across a Large Health System
  • Quality Improvement: Review of Palliative RT wait times at the VA
  • Quality Initiatives - A Tale of Two Institutions: Patient Satisfaction and Safety Surveys
  • Race to the Summit: Impact of a Social Media-based Exercise Competition on Radiation Oncology Physician Physical, Psychological, and Emotional Well-being
  • Racial Disparities in Patients with Endometrial Cancer
  • Radiation decreases formation of heterotopic ossification in a clinically relevant animal model
  • Radiation Oncology Payment Models – Are they data-driven?
  • Radiotherapy resources in central Asia: An International Atomic Energy Agency update
  • Reducing Patient Care Delays in Radiation Oncology Via Optimization of Insurance Pre-Authorization
  • Re-irradiation for Recurrent High-Grade Glioma
  • Report of the ACRO Resident Heidelberg Ion Therapy (HIT) Scholarship Experience
  • Retrospective Review of Swallowing Outcomes for Oropharynx and Larynx Patients after Chemoradiation
  • Revealing the Rurality Rank: A novel evaluation of training opportunities in US radiation oncology residency programs
  • Review of deep learning based autosegmentation for clinical target volume – current status and future directions
  • Self composition and linguistic bias in letters of recommendation for early-career oncologists: an opportunity to improve equity in funding opportunities and career advancement
  • Single Institution Experience of Using 24 Gy in 3 Fractions High Dose Rate Brachytherapy Once a Week Following Chemoradiation in Cervical Cancer
  • Single Institution Radiosurgical Experience of Treating Secretory and Non-Secretory Pituitary Adenomas
  • Social Determinants of Health & Cervical Cancer Outcomes at a Large Academic Institution
  • Stereotactic Body Radiation Therapy Can Be Delivered Safely to Ultracentral Lung Tumors with Excellent Local Control: A Single-Institution Experience
  • Stereotactic Body Radiotherapy for Lung Cancer: An Understandability/Actionability Assessment of YouTube Videos
  • Systemic and Tumor-Directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results of a Phase II Clinical Trial
  • The Economics of Healthcare and How Radiation Oncology is Affected
  • The Impact of H-Index in Predicting Academic Radiation Oncology Promotion
  • The MEDaphor Project: Assessing Readability of Novel Cancer Education Materials with Focus on Patients with Limited Health Literacy
  • The Prevalence of Germline Pathogenic Variants in Radiosensitivity Genes and Incidence of Radiation Toxicities among Patients with Prostate Cancer
  • The Use of ctDNA Testing for Surveillance and Early Detection in Solid Tumors in a Radiation Oncology Practice
  • The use of MRI guided hypofractionated radiation to improve compliance and minimize toxicity in locally advanced cervical cancer
  • Toxicity and Oncologic Outcomes of Proton Radiotherapy for Oropharyngeal Cancer: A Systematic Review and Meta-Analysis
  • Treatment of Recurrent Anaplastic Pleomorphic Xanthoastrocytoma in a 33 Female Previously Diagnosed with WHO Grade I Ganglioglioma
  • Ultrahypofractionated Intensity Modulated Proton Therapy for Prostate Cancer: An Institutional Experience
  • Use of Concurrent Systemic Therapies with Adjuvant Intensity Modulated Proton Beam Therapy (IMPT) in Women with high-risk, locally advanced breast cancers
  • Use of Generative Artificial Intelligence and Large Language Models in Radiation Oncology Education and Research
  • UTILITY OF 6- [18F]-L-FLUORO-L-3, 4-DIHYDROXYPHENYLALANINE POSITRON EMISSION TOMOGRAPHY-MAGNETIC RESONANCE IMAGING (18F-DOPA PET-MRI) METRICS AS A BIOMARKER FOR TREATMENT ASSESSMENT IN SARCOMA PATIENTS
  • Utility of Worst Pattern of Invasion in Guiding Adjuvant Treatment in Early- Stage Oral Cavity Cancer
  • Varying Stereotactic Body Radiotherapy dose-fraction schema in non-small cell lung cancer and the effect on outcomes
  • We Adapt: A Therapist's Perspective on the Origination of Adaptive Radiotherapy Program.
  • What You See Versus What You Are Told: Addressing Appointment Discrepancies in EMR for Radiation Oncology
  • Working From Home - How can Radiation Oncology Navigate Down the Remote Slope
  • Wednesday, March 13, 2024
  • 12:00 PM – 6:00 PM ET
    Registration Desk Open
  • 2:00 PM – 5:00 PM ET
    2024 Coding & Reimbursement Update

    Speaker: Ronald DiGiaimo, MBA, FACHE – Revenue Cycle Coding Strategies

    Speaker: Teri Bedard, BA, RT(R)(T), CPC – Revenue Cycle Coding Strategies

  • 6:00 PM – 7:00 PM ET
    Welcome Reception
  • Thursday, March 14, 2024
  • 7:00 AM – 8:00 AM ET
    Narrative Medicine Workshop

    Moderator: Ria Mulherkar, MD – UPMC Hillman Cancer Center

    Moderator: Eulanca Y. Liu, MD, PhD – UCLA

    Speaker: Matthew J. Farrell, MD, MFA – UCLA

    Moderator: Puja S. Venkat, MD – UCLA

  • 7:00 AM – 5:00 PM ET
    Registration Desk Open
  • 8:00 AM – 8:30 AM ET
    SEAL Welcome Breakfast
  • 8:00 AM – 9:00 AM ET
    Speed Networking for Residents & New Practitioners
  • 8:00 AM – 9:00 AM ET
    Welcome Breakfast
  • 8:15 AM – 9:00 AM ET
    INDUSTRY SYMPOSIUM: Varian
  • 8:30 AM – 8:55 AM ET
    SEAL Welcome, Ice Breaker and Conference Overview
  • 9:00 AM – 9:30 AM ET
    Welcome and Opening Remarks

    Moderator: Dwight Heron, MD, MBA, FACRO, FACR, FASTRO – Bon Secours Mercy Health

  • 9:30 AM – 10:30 AM ET
    Luther Brady Lecture

    Speaker: C. Norman Coleman, MD – National Cancer Institute, NIH

  • 10:30 AM – 11:30 AM ET
    CNS: Neuro-Cognitive Protection: A Giant Leap from Whole Brain Radiation Therapy
    Speaker: Jona Hattangadi-Gluth, MD (she/her/hers) – University of California San Diego
    Speaker: Paul Brown, MD – Mayo Clinic
    PhysicianResident
     CME 1 Credits
  • 10:45 AM – 12:15 PM ET
    Organizational Adaptations for the Future
    SEAL
  • 11:30 AM – 12:15 PM ET
    Meet Your ACRO Exhibitors
  • 11:45 AM – 12:15 PM ET
    Poster Walk with Professors

    Moderator: Michael Bernstein, MD FACRO – Memorial Sloan Kettering Cancer Center

  • 11:45 AM – 12:30 PM ET
    INDUSTRY SYMPOSIUM: Sumitomo Pharmacy & Pfizer Oncology
  • 12:15 PM – 1:15 PM ET
    Diversity, Equity & Inclusion Lunch
  • 12:15 PM – 1:15 PM ET
    Lunch in the Exhibit Hall
  • 12:15 PM – 1:15 PM ET
    SEAL Lunch
  • 1:15 PM – 2:15 PM ET
    GI: Shifting Practices: Standard of Care Evolution for GI Cancers
    Speaker: Nina N. Sanford, MD (she/her/hers) – University of Texas Southwestern
    Speaker: Michael F. Bassetti, MD PhD – University of Wisconsin
    PhysicianResident
     CME 1 Credits
  • 1:15 PM – 2:15 PM ET
    Strategy
    SEAL
  • 2:15 PM – 2:45 PM ET
    ACRO GREC: Addressing Health Policy Head On: A Call to Action

    Presenter: Jason S. McKitrick, MBA – Liberty Partners Group

    Presenter: Tarita Thomas, MD, FACRO

    Panelist: Heath Mackley, MD

    Panelist: Dwight Heron, MD, MBA, FACRO, FACR, FASTRO – Bon Secours Mercy Health

    Panelist: Christopher D. Jahraus, MD, FACRO – Generations Radiotherapy & Oncology PC

    Presenter: Joseph Wilding, n/a – Virginia Commonwealth University

  • 2:45 PM – 3:45 PM ET
    ECONTOUR: Finding or Avoiding Your Bowels Appropriately
    Speaker: Nina N. Sanford, MD (she/her/hers) – University of Texas Southwestern
    Speaker: Michael F. Bassetti, MD PhD – University of Wisconsin
    PhysicianResident
     CME 1 Credits
  • 3:00 PM – 4:00 PM ET
    Workforce Transitions and Employee Retention
    SEAL
  • 3:45 PM – 4:15 PM ET
    Cancer Care Leadership Panel (Industry Panel)
  • 4:15 PM – 5:00 PM ET
    INDUSTRY SYMPOSIUM: Elekta
  • 4:45 PM – 6:15 PM ET
    Reception in the Exhibit Hall
  • 5:15 PM – 6:00 PM ET
    Quick Pitch Oral Presentations

    Moderator: Isabelle Choi, MD – New York Proton Center

  • 6:00 PM – 8:30 PM ET
    ACRO Happy Hour, Quizzo & Corporate Partner Appreciation
  • Friday, March 15, 2024
  • 6:15 AM – 7:15 AM ET
    ACRO IN MOTION: Fun Run/Walk
  • 7:00 AM – 5:00 PM ET
    Registration Desk Open
  • 7:15 AM – 8:00 AM ET
    Breakfast in the Exhibit Hall
  • 7:15 AM – 8:00 AM ET
    INDUSTRY SYMPOSIUM: Lantheus
  • 8:00 AM – 9:00 AM ET
    ADVANCED MODALITIES. Cardiac Toxicity in Thoracic Radiation Oncology: Heart of the Matter or Doesn’t Matter?
    Speaker: Charles B. Simone, II, MD, FASTRO, FACRO – New York Proton Center/Memorial Sloan Kettering Cancer Center
    Speaker: Vlad G. Zaha, MD, PhD (he/him/his) – UT Southwestern
    Speaker: Arya Amini, MD – City of Hope National Medical Center
    PhysicianResident
     CME 1 Credits
  • 8:00 AM – 9:00 AM ET
    Implementations and Creating Dynamic Programs
    SEAL
  • 9:00 AM – 10:00 AM ET
    Future of Cancer Care Discussion Panel

    Panelist: Laeton J. Pang, MD MPH FACR FACRO FACCC FASTRO – Association of Freestanding Radiation Oncology Centers

    Panelist: Dwight Heron, MD, MBA, FACRO, FACR, FASTRO – Bon Secours Mercy Health

    Panelist: David R. Penberthy, MD MBA – University of Virginia

    Panelist: Sameer Keole, MD – Mayo Clinic

    Panelist: Iris Gibbs, MD FACR FASTRO

    Moderator: Joanne Dragun, MD – Halifax hospital

  • 9:00 AM – 10:30 AM ET
    Quality
    SEAL
  • 10:00 AM – 11:00 AM ET
    Break in the Exhibit Hall
  • 10:00 AM – 11:00 AM ET
    Cases with the Experts: Residents & New Practitioners

    Moderator: Grant McKenzie, MD – University of Lousiville

  • 10:30 AM – 10:40 AM ET
    Product Theater: GammaTile, STaRT the New Era of Brain Brachytherapy
  • 10:45 AM – 12:15 PM ET
    Patient Experience
    SEAL
  • 11:00 AM – 12:30 PM ET
    BREAST: Navigating Breast Cancer Treatment Paradigms and Toxicities from Early Stage to Inflammatory
    Speaker: Robert Mutter, MD – Mayo Clinic
    Speaker: Amy Xu, MD PhD – Memorial Sloan Kettering Cancer Center
    Speaker: Sara Alcorn, MD, MPH, PhD – University of Minnesota
    PhysicianResident
     CME 1.5 Credits
  • 12:30 PM – 1:30 PM ET
    GREC Committee Meeting
  • 12:30 PM – 1:30 PM ET
    Lunch in the Exhibit Hall
  • 12:30 PM – 1:30 PM ET
    Sucha Asbell Women's Lunch
  • 12:45 PM – 1:15 PM ET
    Poster Walk with Professors

    Moderator: Michael Bernstein, MD FACRO – Memorial Sloan Kettering Cancer Center

  • 1:30 PM – 2:00 PM ET
    Quick Pitch Oral Presentations

    Moderator: Isabelle Choi, MD – New York Proton Center

  • 1:30 PM – 2:15 PM ET
    Final Break in the Exhibit Hall
  • 2:00 PM – 2:15 PM ET
    Live Auction for Raffle Prizes
  • 2:15 PM – 2:45 PM ET
    ACRO Updates

    Presenter: Jaroslaw Hepel, MD, FACRO – Brown University/Rhode Island Hospital

  • 2:45 PM – 4:15 PM ET
    GU: Organ Preservation and Personalization: Advancing Paradigms for Prostate, Bladder, and Kidney Cancer
    Speaker: Jason A. Efstathiou, MD, DPhil (he/him/his) – Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
    Speaker: Anand Swaminath, MD – McMaster University/ Juravinski Cancer Centre
    Speaker: Julie Kang, MD PhD (she/her/hers) – Yale University
    PhysicianResident
     CME 1.5 Credits
  • 4:15 PM – 5:00 PM ET
    INDUSTRY SYMPOSIUM: AstraZeneca
  • 5:00 PM – 6:00 PM ET
    Awards Celebration
  • 6:00 PM – 7:30 PM ET
    President's Celebration
  • Saturday, March 16, 2024
  • 6:15 AM – 7:15 AM ET
    ACRO IN MOTION: Yoga
  • 7:00 AM – 8:30 AM ET
    Farewell Continental Breakfast
  • 7:00 AM – 12:00 PM ET
    Registration Desk Open
  • 7:30 AM – 8:30 AM ET
    Poster Walk with Professors

    Moderator: Michael Bernstein, MD FACRO – Memorial Sloan Kettering Cancer Center

  • 8:30 AM – 9:30 AM ET
    LUNG: Common and Uncommon Emerging Indications for Thoracic Cancers
    Speaker: Joe Chang, MD – MD Anderson Cancer Center Houston
    Speaker: Andreas Rimner, MD (he/him/his) – Department of Radiation Oncology, University of Freiburg
    PhysicianResident
     CME 1 Credits
  • 9:30 AM – 10:30 AM ET
    HEAD/NECK: Cut Less, Zap More: Organ Preservation for Head & Neck Malignancies
    Speaker: Anna Lee, MD, MPH (she/her/hers) – University of Texas MD Anderson Cancer Center
    Speaker: David Schwartz, MD – UTHSC College of Medicine Department of Radiation Oncology
    PhysicianResident
     CME 1 Credits
  • 10:30 AM – 11:00 AM ET
    ACRO Updates

    Presenter: Christopher D. Jahraus, MD, FACRO – Generations Radiotherapy & Oncology PC

  • 11:00 AM – 12:00 PM ET
    GYN: Same Great Radiation, but with New Indications for GYN Cancers
    Speaker: Idalid Franco, MD, MPH (she/her/ella) – Brigham and Women's Hospital and Dana-Farber Cancer Institute Department of Radiation Oncology
    Speaker: Junzo Chino, MD (he/him/his) – Duke University
    PhysicianResident
     CME 1 Credits
  • 12:00 PM – 1:00 PM ET
    Resident & New Practitioner Lunch
  • 12:15 PM – 12:45 PM ET
    Tips from New Practitioner Panel
  • 1:00 PM – 3:00 PM ET
    Resident Symposium